Form 8-K - Current report:
SEC Accession No. 0001615774-16-006086
Filing Date
2016-06-27
Accepted
2016-06-27 17:15:15
Documents
1
Period of Report
2016-06-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s103580_8k.htm 8-K 10470
  Complete submission text file 0001615774-16-006086.txt   11705
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54478 | Film No.: 161734079
SIC: 2834 Pharmaceutical Preparations